MYC and colorectal carcinoma: Chai revealed a novel therapeutic mechanism of cucurbitacin B, namely, inhibition of the proliferation and invasion of CRC cells and promotion of apoptosis via inhibition of Hippo-YAP signaling and its downstream target genes Cyr 61 and c-Myc in CRC cells (196).